• 8555 Citations
  • 51 h-Index
1983 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Powel H Brown is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Breast Medicine & Life Sciences
Transcription Factor AP-1 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Retinoids Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

Epidermal Growth Factor
Breast Neoplasms
Neutropenia
Thrombocytopenia
Therapeutics
1 Citation (Scopus)

Randomized double-blind placebo-controlled biomarker modulation study of Vitamin D supplementation in premenopausal women at high risk for breast cancer (SWOG S0812)

Crew, K. D., Anderson, G. L., Hershman, D. L., Terry, M. B., Tehranifar, P., Lew, D. L., Yee, M., Brown, E. A., Kairouz, S. S., Kuwajerwala, N., Bevers, T. B., Doster, J. E., Zarwan, C., Kruper, L., Minasian, L. M., Ford, L., Arun, B. K., Neuhouser, M., Goodman, G. E. & Brown, P. H., Jan 1 2019, In : Cancer Prevention Research. 12, 7, p. 481-490 10 p.

Research output: Contribution to journalArticle

Vitamin D
Biomarkers
Placebos
Breast Neoplasms
Somatomedins

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression

Mazumdar, A., Tahaney, W. M., Bollu, L. R., Poage, G., Hill, J., Zhang, Y., Mills, G. B. & Brown, P. H., Dec 1 2019, In : npj Breast Cancer. 5, 1, 22.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Protein Phosphatase 2
Phosphoric Monoester Hydrolases
Estrogen Receptors
Cell Cycle
2 Citations (Scopus)

A randomized multicenter Phase II study of docosahexaenoic acid in patients with a history of breast cancer, premalignant lesions, or benign breast disease

Gucalp, A., Zhou, X. K., Cook, E. D., Garber, J. E., Crew, K. D., Nangia, J. R., Bhardwaj, P., Giri, D. D., Elemento, O., Verma, A., Wang, H., Lee, J-K. J., Vornik, L. A., Mays, C., Weber, D., Sepeda, V., O'Kane, H., Krasne, M., Williams, S., Morris, P. G. & 5 others, Heckman-Stoddard, B. M., Dunn, B. K., Hudis, C. A., Brown, P. H. & Dannenberg, A. J., Apr 1 2018, In : Cancer Prevention Research. 11, 4, p. 203-214 12 p.

Research output: Contribution to journalArticle

Breast Diseases
Docosahexaenoic Acids
Breast Neoplasms
Breast
Placebos
2 Citations (Scopus)
Estrogen Receptor Modulators
Hyperplasia
Neoplasms
Therapeutics
Patient Compliance